z-logo
Premium
Primary conjunctival mast cell tumor in a Labrador Retriever
Author(s) -
Barsotti Giovanni,
Marchetti Veronica,
Abramo Francesca
Publication year - 2007
Publication title -
veterinary ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.594
H-Index - 50
eISSN - 1463-5224
pISSN - 1463-5216
DOI - 10.1111/j.1463-5224.2007.00502.x
Subject(s) - labrador retriever , medicine , pathology , palpebral fissure , mast cell , conjunctiva , biopsy , cd117 , trabecular meshwork , cytology , ophthalmology , glaucoma , cd34 , biology , stem cell , genetics , immunology
A 4‐year‐old, intact male Labrador Retriever with a rapidly progressive conjunctival mass was evaluated. Ocular examination showed a 2‐cm elongated mass arising from the superior bulbar conjunctiva of the left eye. The mass resulted in distortion of the palpebral fissure and contacted the superior aspect of the cornea without modifying its structure; no adhesion to the sclera was detected. The superior palpebral conjunctiva was unaffected, and the remaining ocular examination was normal. The initial diagnostic work‐up included CBC, serum biochemical analysis, urinalysis, and fine needle biopsy of the mass. A poorly differentiated mast cell tumor was diagnosed by cytology. Immunocytochemistry was performed to evaluate Ki‐67 proliferation index, and 54/1000 tumoral nuclei showed a dark red staining. After a complete clinical staging, the mass was excised and identified histologically as a grade‐II mast cell tumor. An adjuvant treatment with prednisone and vinblastine was instituted because of the limited excisional margins. No evidence of local recurrence or metastasis has been apparent during the 29‐month follow‐up period. This report contributes to the current literature pertaining to canine conjunctival mast cell tumors; unfortunately, the paucity of case reports and the absence of large studies regarding this tumor make conclusions regarding its biologic behavior impossible.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here